Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/22405
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rigau, Marc | - |
dc.contributor.author | Ostrouska, Simone | - |
dc.contributor.author | Fulford, Thomas S | - |
dc.contributor.author | Johnson, Darryl N | - |
dc.contributor.author | Woods, Katherine | - |
dc.contributor.author | Ruan, Zheng | - |
dc.contributor.author | McWilliam, Hamish E G | - |
dc.contributor.author | Hudson, Christopher | - |
dc.contributor.author | Tutuka, Candani | - |
dc.contributor.author | Wheatley, Adam K | - |
dc.contributor.author | Kent, Stephen J | - |
dc.contributor.author | Villadangos, Jose A | - |
dc.contributor.author | Pal, Bhupinder | - |
dc.contributor.author | Kurts, Christian | - |
dc.contributor.author | Simmonds, Jason | - |
dc.contributor.author | Pelzing, Matthias | - |
dc.contributor.author | Nash, Andrew D | - |
dc.contributor.author | Hammet, Andrew | - |
dc.contributor.author | Verhagen, Anne M | - |
dc.contributor.author | Vairo, Gino | - |
dc.contributor.author | Maraskovsky, Eugene | - |
dc.contributor.author | Panousis, Con | - |
dc.contributor.author | Gherardin, Nicholas A | - |
dc.contributor.author | Cebon, Jonathan S | - |
dc.contributor.author | Godfrey, Dale I | - |
dc.contributor.author | Behren, Andreas | - |
dc.contributor.author | Uldrich, Adam P | - |
dc.date | 2020-01-09 | - |
dc.date.accessioned | 2020-01-13T04:06:12Z | - |
dc.date.available | 2020-01-13T04:06:12Z | - |
dc.date.issued | 2020-02-07 | - |
dc.identifier.citation | Science 2020; 367(6478): eaay5516 | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/22405 | - |
dc.description.abstract | Gamma delta (γδ) T cells are essential to protective immunity. In humans, most γδ T cells express Vγ9Vδ2+ T cell receptors (TCRs) that respond to phosphoantigens (pAg) produced by cellular pathogens and overexpressed by cancers. However, the molecular targets recognized by these γδTCRs are unknown. Here, we identify butyrophilin 2A1 (BTN2A1) as a key ligand that binds to the Vγ9+ TCR γ-chain. BTN2A1 associates with another butyrophilin, BTN3A1, which act together to initiate responses to pAg. Furthermore, binding of a second ligand, possibly BTN3A1, to a separate TCR domain incorporating Vδ2 is also required. This unique mode of Ag-dependent T cell activation advances our understanding of diseases involving pAg recognition and creates opportunities for the development of γδ T cell-based immunotherapies. | en |
dc.language.iso | eng | - |
dc.title | Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Science | en |
dc.identifier.affiliation | University of Bonn, Bonn, Germany | en |
dc.identifier.affiliation | Department of Microbiology & Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia | en |
dc.identifier.affiliation | Ludwig Institute for Cancer Research, Melbourne -Austin Branch Victoria 3084, Australia | en |
dc.identifier.affiliation | Australian Research Council Centre of Excellence for Advanced Molecular Imaging at the University of Melbourne, Victoria 3010, Australia | en |
dc.identifier.affiliation | Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia | en |
dc.identifier.affiliation | School of Cancer Medicine, La Trobe University, Heidelberg, Victoria 3084, Australia | en |
dc.identifier.affiliation | Department of Biochemistry and Molecular Biology at the Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3010, Australia | en |
dc.identifier.affiliation | Australian Research Council Centre of Excellence for Convergent Bio-Nano Science and Technology at the University of Melbourne, Victoria 3010, Australia | en |
dc.identifier.affiliation | Department of Medicine, The University of Melbourne, Melbourne, Victoria 3010, Australia | en |
dc.identifier.affiliation | CSL Limited at the Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3010, Australia | en |
dc.identifier.affiliation | University of Bonn, Bonn, Germany | en |
dc.identifier.doi | 10.1126/science.aay5516 | en |
dc.type.content | Text | en |
dc.identifier.orcid | 0000-0001-5978-1073 | en |
dc.identifier.orcid | 0000-0001-7582-3990 | en |
dc.identifier.orcid | 0000-0003-3474-3104 | en |
dc.identifier.orcid | 0000-0003-3479-3419 | en |
dc.identifier.orcid | 0000-0002-1420-6988 | en |
dc.identifier.orcid | 0000-0003-3344-4102 | en |
dc.identifier.orcid | 0000-0002-5593-9387 | en |
dc.identifier.orcid | 0000-0002-8539-4891 | en |
dc.identifier.orcid | 0000-0001-6771-8891 | en |
dc.identifier.orcid | 0000-0002-6620-2401 | en |
dc.identifier.orcid | 0000-0003-1947-8701 | en |
dc.identifier.orcid | 0000-0003-1330-7303 | en |
dc.identifier.orcid | 0000-0002-6945-8672 | en |
dc.identifier.orcid | 0000-0003-3690-6253 | en |
dc.identifier.orcid | 0000-0003-4690-2571 | en |
dc.identifier.orcid | 0000-0002-3898-950X | en |
dc.identifier.orcid | 0000-0002-3009-5472 | en |
dc.identifier.orcid | 0000-0001-5329-280X | en |
dc.identifier.orcid | 0000-0002-6350-5976 | en |
dc.identifier.pubmedid | 31919129 | - |
dc.type.austin | Journal Article | - |
local.name.researcher | Cebon, Jonathan S | |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.openairetype | Journal Article | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Olivia Newton-John Cancer Research Institute | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.